Health
1 read
FDA Approves New Gene Therapy for Sickle Cell Disease in Children

Want the full story?
Read the complete article at KTSM
AI Summary
The U.S. Food and Drug Administration has granted approval for a groundbreaking gene therapy aimed at treating children aged 2 and older suffering from sickle cell disease. This innovative treatment is significant as it offers a new option for managing a condition that affects thousands of children across the country. The approval marks a crucial advancement in medical care for those impacted by this hereditary blood disorder, potentially improving their quality of life and health outcomes. Families with children diagnosed with sickle cell disease should consult their healthcare providers about this new treatment option.
health fda gene-therapy sickle-cell
People & Organizations
U.S. Food and Drug Administration